# A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D

Study · id `cardio:ct-nct01222884` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01222884](<https://clinicaltrials.gov/study/NCT01222884>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01222884

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 351 participants.

## Technical summary

Registry record NCT01222884. Randomized; no masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2013-10 (actual). Results posted on 2015-07-24.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 351 participants (enrolled count; ClinicalTrials.gov record NCT01222884, source copy `cardio:ctgov-nct01222884-2015-12-02`, retrieved 2026-10-26)
- Start date: 2011-06 (registry gives no type) (ClinicalTrials.gov record NCT01222884, source copy `cardio:ctgov-nct01222884-2015-12-02`, retrieved 2026-10-26)
- Primary completion: 2013-10 (actual) (ClinicalTrials.gov record NCT01222884, source copy `cardio:ctgov-nct01222884-2015-12-02`, retrieved 2026-10-26)
- Completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01222884, source copy `cardio:ctgov-nct01222884-2015-12-02`, retrieved 2026-10-26)
- Results first posted: 2015-07-24 (ClinicalTrials.gov record NCT01222884, source copy `cardio:ctgov-nct01222884-2015-12-02`, retrieved 2026-10-26)
- Countries: India (ClinicalTrials.gov record NCT01222884, source copy `cardio:ctgov-nct01222884-2015-12-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01222884-2015-12-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D
- Condition: Chronic Kidney Disease Stage 5 (Dialysis Dependent)
- Intervention (Drug): Monofer
- Intervention (Drug): Iron sucrose
- Lead sponsor: Pharmacosmos A/S
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Pharmacosmos A/S (`cardio:org-pharmacosmos-a-s`)

## Provenance

Content hash: 6fee3049c2751f7b013edfbd9b890bd9e64b478b09247d61f67e78b78c2e04a6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
